Characterising CD8+ T cell transcriptomic and clonal consequences of immune checkpoint blockade for the treatment of cancer

Characterising CD8+ T cell transcriptomic and clonal consequences of immune checkpoint blockade for the treatment of cancer

<p><b>Background:</b> Immune checkpoint blockade (ICB) is arguably the greatest advance in medical oncology this century. Nonetheless, responses are highly variable. Mechanistic insights into this heterogeneity promises to improve patient stratification and identification of thera...

Полное описание

Библиографические подробности
Главный автор:	Watson, RA
Другие авторы:	Fairfax, B
Формат:	Диссертация
Язык:	English
Опубликовано:	2023
Предметы:	Immunology Immuno-oncology Oncology, Experimental

Схожие документы

Immune Checkpoint Blockade sensitivity and Progression-Free Survival associates with baseline CD8+ T cell clone size and cytotoxicity
по: Watson, R, и др.
Опубликовано: (2021)

Dissecting peripheral CD8+ T cell responses and immune interactions during immune checkpoint blockade for metastatic melanoma
по: Tong, O
Опубликовано: (2023)

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
по: Cristina Valero, и др.
Опубликовано: (2023-10-01)

Mathematical modelling and transcriptional characterisation of intratumoral regulatory T cell sub-populations
по: Muzhingi, I
Опубликовано: (2023)

Further Advances in Cancer Immunotherapy: Going Beyond Checkpoint Blockade
по: Robert W. Wilkinson, и др.
Опубликовано: (2018-06-01)

New approaches to treating cancer using immune-checkpoint blockade
по: Fellermeyer, M
Опубликовано: (2023)

Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade
по: Jun Gong, и др.
Опубликовано: (2018-10-01)

Treating ICB-resistant glioma with anti-CD40 and mitotic spindle checkpoint controller BAL101553 (lisavanbulin)
по: Vassilis Genoud, и др.
Опубликовано: (2021-11-01)

Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression
по: Joseph S. Dolina, и др.
Опубликовано: (2023-09-01)

Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell–mediated antitumor immunity
по: Xiaoxin Ren, и др.
Опубликовано: (2022-11-01)

IL-1 receptor–associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy
по: Gürcan Tunalı, и др.
Опубликовано: (2023-04-01)

Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas
по: Virginia Laspidea, и др.
Опубликовано: (2022-04-01)

EBAG9 controls CD8+ T cell memory formation responding to tumor challenge in mice
по: Armin Rehm, и др.
Опубликовано: (2022-06-01)

Intrinsic RIG-I restrains STAT5 activation to modulate antitumor activity of CD8+ T cells
по: Xinyi Jiang, и др.
Опубликовано: (2023-05-01)

CD206+ tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity
по: Madhura Modak, и др.
Опубликовано: (2022-06-01)

Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancer
по: Kentaro Masuhiro, и др.
Опубликовано: (2022-05-01)

Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer
по: Colt A. Egelston, и др.
Опубликовано: (2022-02-01)

CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy
по: Miriam Y. Kim, и др.
Опубликовано: (2021-08-01)

Decitabine priming increases anti–PD-1 antitumor efficacy by promoting CD8+ progenitor exhausted T cell expansion in tumor models
по: Xiang Li, и др.
Опубликовано: (2023-04-01)

Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell– and CXCR3-dependent manner
по: Michael Brandon Ware, и др.
Опубликовано: (2023-04-01)

Thromboembolic Events Related to Treatment with Checkpoint Inhibitors: Report of Two Cases
по: Jessica Tsukamoto, и др.
Опубликовано: (2018-10-01)

Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer
по: Elizabeth Comen, и др.
Опубликовано: (2024-02-01)

Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis
по: Tiina E. Kähkönen, и др.
Опубликовано: (2021-06-01)

Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses
по: Gabrielle Romain, и др.
Опубликовано: (2022-09-01)

Editorial: Tumor microenvironment complexity and its therapeutic implications
по: Denner Santos dos Anjos, и др.
Опубликовано: (2025-01-01)

Circulating biomarkers in the diagnosis and prognosis of immune checkpoint inhibitor-related myocarditis: time for a risk-based approach
по: Gillian Murtagh, и др.
Опубликовано: (2024-02-01)

PD-1 and ICOS coexpression identifies tumor-reactive CD4+ T cells in human solid tumors
по: Rebekka Duhen, и др.
Опубликовано: (2022-06-01)

Immune regulatory networks in inflammation-driven cancer
по: Franchini, F
Опубликовано: (2017)

A PDGFRB- and CD40-targeting bispecific AffiMab induces stroma-targeted immune cell activation
по: Alessandro Mega, и др.
Опубликовано: (2023-12-01)

Tumor cells fail to present MHC-II–restricted epitopes derived from oncogenes to CD4+ T cells
по: Spencer E. Brightman, и др.
Опубликовано: (2023-01-01)

CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer
по: Masayo Ukita, и др.
Опубликовано: (2022-06-01)

A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity
по: Diana I. Albu, и др.
Опубликовано: (2024-12-01)

IL-32γ potentiates tumor immunity in melanoma
по: Thomas Gruber, и др.
Опубликовано: (2020-09-01)

Anti–PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC
по: Eric Tu, и др.
Опубликовано: (2022-02-01)

MMP2 and TLRs modulate immune responses in the tumor microenvironment
по: Luciana R. Muniz-Bongers, и др.
Опубликовано: (2021-06-01)

Tim-3 mediates T cell trogocytosis to limit antitumor immunity
по: Ornella Pagliano, и др.
Опубликовано: (2022-05-01)

The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma
по: Tyler J. Alban, и др.
Опубликовано: (2023-07-01)

Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer
по: Siqi Chen, и др.
Опубликовано: (2022-07-01)

Integrated T cell cytometry metrics for immune-monitoring applications in immunotherapy clinical trials
по: Dimitrios N. Sidiropoulos, и др.
Опубликовано: (2022-10-01)

The proto-oncogene SRC phosphorylates cGAS to inhibit an antitumor immune response
по: William Dunker, и др.
Опубликовано: (2023-06-01)